官方服务：
资源简介：
Are describes patents of anti-OX40 antibodies
本数据集对有关抗OX40抗体（anti-OX40 antibodies）的专利进行了阐述
应用场景：
创建时间：
2024-01-23
相关数据集
Supplementary Material for: A Single-Center, Case-Control Study of Low-Dose-Induction Oral Immunotherapy with Cow's Milk
Background: This study aimed to investigate the efficacy and safety of low-dose-induction oral immunotherapy (OIT) with 3 ml of milk, which is a lower target volume than is conventionally used. Method
Mendeley Data2024-06-25 更新90
Supplementary Material for: A Case of Successful Treatment with an Immune Checkpoint Inhibitor after Head and Neck Photoimmunotherapy
Introduction: Head and neck photoimmunotherapy (HN-PIT) has been conditionally approved by the Japanese government for the treatment of unresectable locally advanced or locally recurrent
DataCite Commons2024-01-30 更新80
Supplementary Material for: Atezolizumab-induced acrodermatitis and pustular psoriasis in a patient with Non-Small Cell Lung Carcinoma (NSCLC): a rare case report.
Immune checkpoint inhibitors are new drugs approved for the treatment of many types of malignancies. Despite their wide use and unquestionable clinical benefits, these agents have been also associated
DataCite Commons2025-06-01 更新50
CD8+ T cell differentiation status correlates with the feasibility of sustained unresponsiveness following oral immunotherapy
While food allergy oral immunotherapy (OIT) can provide safe and effective desensitization (DS), the immune mechanisms underlying development of sustained unresponsiveness (SU) following a period of a
Mendeley Data2024-05-10 更新80
Additional file 6 of A blinded, randomized and controlled multicenter clinical trial to assess the efficacy and safety of Leisguard® as an immunotherapeutic treatment for healthy Leishmania infantum-seropositive dogs
Additional file 6: Table S5. IFN-γ concentration of the dogs at the beginning and end of the study.
DataCite Commons2024-08-15 更新60
